Oxygen-radical/nitric oxide mediate calcium-dependent hormone action on cyclic GMP system: A novel concept in signal transduction mechanisms
- 1 August 1995
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular and Cellular Biochemistry
- Vol. 149-150 (1), 257-262
- https://doi.org/10.1007/bf01076585
Abstract
The broad objective of these studies was to understand the nature of cyclic GMP system and the mechanism(s) whereby hormone, autacoids and drugs alter this signal in various physiological systems. Studies were undertaken on the modulation of guanylate cyclase activity by oxygen-radicals/nitric oxide and the mechanism(s) of generation of nitric oxide by receptor-selective hormones. We observed that cytosolic guanylate cyclase undergoes significant stimulation in the presence of oxygen-radicals/nitric oxide. This activation by nitric oxide can be reversed by hemeproteins, thus, enabling guanylate cyclase system to cycle between activated and deactivated state. The evidence is presented that oxygen-radicals are required for the synthesis of nitric oxide by NO synthase as demonstrated by inhibition of NO formation by oxygen-radical scavengers. And finally, the data is presented that acetylcholine-induced elevations of intracellular levels of cyclic GMP can be attenuated by muscarinic antagonist, atropine and superoxide anion scavenger, nitroblue tetrazolium. These observations establish a novel concept that activation of hormone receptors on the cell surface, triggers generation of oxygen radicals and hydrogen peroxide which participates in the catalytic conversion of L-arginine to nitric oxide by nitric oxide synthase in the presence of calcium ion. The oxygen-radicals/NO, thus formed, oxidatively activate guanylate cyclase and transduce the message of calcium-dependent hormones.Keywords
This publication has 35 references indexed in Scilit:
- Nitric Oxide Synthase: Involvement of Oxygen Radicals in Conversion of L-Arginine to Nitric OxideBiochemical and Biophysical Research Communications, 1993
- Isoforms of nitric oxide synthase Characterization and purification from different cell typesBiochemical Pharmacology, 1991
- Nω-Nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cellsCanadian Journal of Physiology and Pharmacology, 1990
- A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateBiochemistry, 1988
- Effects of Nitrovasodilators, Endothelium-dependent Vasodilators, and Atrial Peptides on cGMPCold Spring Harbor Symposia on Quantitative Biology, 1988
- Atriopeptin II and nitrovasodilator-mediated shifts in guanosine 3′,5′-cyclic monophosphate in rat thoracic aorta: Evidence for involvement of distinct guanylate cyclase poolsEuropean Journal of Pharmacology, 1985
- Synthesis of adenosine 3′,5′-monophosphate by guanylate cyclase, a new pathway for its formationBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclaseNature, 1975
- Reactions of Methæmo-Globin and Catalase with Peroxides and Hydrogen DonorsNature, 1954